동국제약

086450KOSDAQ의약품 제조업

62.5 / 100

Reference Date: 2026-07-24

Financial Score27.5 / 40

News Sentiment18.1 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average and the debt ratio is very low with excellent financial health is also solid. Slightly up 2.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dongkook Pharmaceutical, established in 1968, aims to become South Korea's leading total healthcare group by focusing on new product development and global market expansion. The company offers a wide range of products in over-the-counter drugs, specialty pharmaceuticals, and healthcare sectors, and has successfully exported its products to countries such as China, Japan, and Europe.

Number of Employees

1,306people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.49Industry Average 11.233.0Point

Higher than industry avg (caution)

PBR

1.10Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE

10.25Industry Average 4.017.0Point

2.6x industry avg (excellent)

Debt Ratio

4.16Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲12.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲20.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 9.7% (improving, 3yr)

Detailed News Sentiment

25 totalPositive 17Neutral 8Negative 0Average Sentiment Score 72.2

Neutral
“썬크림 자주 덧바르기 불편할 땐…” 동국제약 패드형 자외선 차단...
동국제약의 새로운 패드형 자외선 차단제 출시로 편의성 향상 기대되나, 직접적인 주가 영향은 제한적.
Positive
"패드형 자외선 차단제"…동국제약, 신제품 출시
동국제약의 신제품 패드형 자외선 차단제 출시로 인해 여름철 시장 경쟁력 강화 및 소비자 편의성 증대 기대.
Positive
[바이오톺아보기] ‘마데카솔’ 신화 넘어 1兆 판 키우는 동국제약….....
동국제약이 창립 후 최초로 연매출 1조원 달성 전망으로 긍정적인 성장 전망을 보임.

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 18,570Won52-week high 29,90052-week low 16,420

1-month return4.0Point

1m +2.09% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0